STM Journals Peer-reviewed research from Consortium e-Learning Network

Research and Reviews : A Journal of Biotechnology Review Article

Drugs Design and Process Chemistry: A Factuality Study of Recent Advance in Drug Delivery Systems – A Comprehensive Review

  1. Mohd. Wasiullah Department of Pharmacy, Prasad Institute of Technology, Jaunpur
  2. Piyush Yadav Department of Pharmacy, Prasad Institute of Technology, Jaunpur
  3. Shashikant Maury Department of Pharmacy, Prasad Institute of Technology, Jaunpur
  4. Neha Department of Pharmacy, Prasad Institute of Technology, Jaunpur

Abstract

Recent years have seen significant advances in drug design and process chemistry, mostly due to breakthroughs in drug delivery technologies. This study provides a thorough examination of current developments in drug delivery, emphasizing strategies that improve therapeutic efficacy, reduce adverse effects, and maximize pharmacokinetic profile. The effects of several strategies on drug stability, solubility, and bioavailability are examined, including controlled-release systems, targeted delivery methods, and nanoparticle-based delivery. This review also highlights the significance of green chemistry and sustainable practices while examining the function of process chemistry in scaling up drug manufacture to satisfy regulatory criteria. We analyze current trends, issues, and potential paths in the subject using a factual (flexible and factual) approach, offering a fundamental resource for scholars.

Keywords

References (27)

  1. Rayaprolu BM, Strawser JJ, Anyarambhatla G. Excipients in parenteral formulations: selection considerations and effective utilization with small molecules and biologics. Drug Development and Industrial Pharmacy. 2018;44(10):1565-1571. doi:10.1080/03639045.2018.1483392
  2. Vargason AM, Anselmo AC, Mitragotri S. The evolution of commercial drug delivery technologies. Nature Biomedical Engineering. 2021;5(9):951-967. doi:10.1038/s41551-021-00698-w
  3. Alqahtani MS, Kazi M, Alsenaidy MA, Ahmad MZ. Advances in Oral Drug Delivery. Frontiers in Pharmacology. 2021;12. doi:10.3389/fphar.2021.618411
  4. Danhier F, Feron O, Préat V. To exploit the tumor microenvironment: Passive and active tumor targeting of nanocarriers for anti-cancer drug delivery. Journal of Controlled Release. 2010;148(2):135-146. doi:10.1016/j.jconrel.2010.08.027
  5. Agrahari V. Novel drug delivery systems, devices, and fabrication methods. Drug Delivery and Translational Research. 2017;8(2):303-306. doi:10.1007/s13346-017-0459-3
  6. Patra JK, Das G, Fraceto LF, Campos EVR, Rodriguez-Torres MDP, Acosta-Torres LS, et al. Nano based drug delivery systems: recent developments and future prospects. Journal of Nanobiotechnology. 2018;16(1). doi:10.1186/s12951-018-0392-8
  7. Li X, Szewczuk M, Malardier-Jugroot C. Folic acid-conjugated amphiphilic alternating copolymer as a new active tumor targeting drug delivery platform. Drug Design, Development and Therapy. 2016;Volume10:4101-4110. doi:10.2147/dddt.s123386
  8. Mehrdadi S. Drug Delivery of Solid Lipid Nanoparticles (SLNs) and Nanostructured Lipid Carriers (NLCs) to Target Brain Tumors. Advanced Pharmaceutical Bulletin. 2022;13(3):512-520. doi:10.34172/apb.2023.062
  9. Doytchinova I. Drug Design—Past, Present, Future. Molecules. 2022;27(5):1496. doi:10.3390/molecules27051496
  10. Hughes J, Rees S, Kalindjian S, Philpott K. Principles of early drug discovery. British Journal of Pharmacology. 2011;162(6):1239-1249. doi:10.1111/j.1476-5381.2010.01127.x
  11. Fogel DB. Factors associated with clinical trials that fail and opportunities for improving the likelihood of success: A review. Contemporary Clinical Trials Communications. 2018;11:156-164. doi:10.1016/j.conctc.2018.08.001
  12. Patton EE, Zon LI, Langenau DM. Zebrafish disease models in drug discovery: from preclinical modelling to clinical trials. Nature Reviews Drug Discovery. 2021;20(8):611-628. doi:10.1038/s41573-021-00210-8
  13. Cassar S, Adatto I, Freeman JL, Gamse JT, Iturria I, Lawrence C, et al. Use of zebrafish in drug discovery toxicology. Chem Res Toxicol. 2019;33(1):95–118. doi:10.1021/acs.
  14. chemrestox.9b00335.
  15. MacRae CA, Peterson RT. Zebrafish as tools for drug discovery. Nature Reviews Drug Discovery. 2015;14(10):721-731. doi:10.1038/nrd4627
  16. Guerra-Farfan E, Garcia-Sanchez Y, Jornet-Gibert M, Nuñez JH, Balaguer-Castro M, Madden K. Clinical practice guidelines: The good, the bad, and the ugly. Injury. 2023;54:S26-S29. doi:10.1016/j.injury.2022.01.047
  17. Cięszczyk N, Czech M, Pronicki Ł, Gujski M. Knowledge and Beliefs about Clinical Trials among Adults in Poland: A Cross-Sectional Study. Clinics and Practice. 2024;14(4):1285-1295. doi:10.3390/clinpract14040104
  18. Jose C, Amra K, Bhavsar C, Momin M, Omri A. Polymeric Lipid Hybrid Nanoparticles: Properties and Therapeutic Applications. Critical Reviews™ in Therapeutic Drug Carrier Systems. 2018;35(6):555-588. doi:10.1615/critrevtherdrugcarriersyst.2018024751
  19. Pérez-Herrero E, Fernández-Medarde A. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy. European Journal of Pharmaceutics and Biopharmaceutics. 2015;93:52-79. doi:10.1016/j.ejpb.2015.03.018
  20. Choudhury H, Gorain B, Pandey M, Khurana RK, Kesharwani P. Strategizing biodegradable polymeric nanoparticles to cross the biological barriers for cancer targeting. International Journal of Pharmaceutics. 2019;565:509-522. doi:10.1016/j.ijpharm.2019.05.042
  21. Rizwanullah M, Alam M, Harshita, Mir SR, Rizvi MMA, Amin S. Polymer-Lipid Hybrid Nanoparticles: A Next-Generation Nanocarrier for Targeted Treatment of Solid Tumors. Current Pharmaceutical Design. 2020;26(11):1206-1215. doi:10.2174/1381612826666200116150426
  22. Mohanty A, Uthaman S, Park IK. Utilization of Polymer-Lipid Hybrid Nanoparticles for Targeted Anti-Cancer Therapy. Molecules. 2020;25(19):4377. doi:10.3390/molecules25194377
  23. Girelli AM, Astolfi ML, Scuto FR. Agro-industrial wastes as potential carriers for enzyme immobilization: A review. Chemosphere. 2020;244:125368. doi:10.1016/j.chemosphere.
  24. 2019.125368.
  25. Chandrasekhar S, Satyanarayana KG, Pramada PN, Raghavan P, Gupta TN. Review Processing, properties and applications of reactive silica from rice husk—an overview. Journal of Materials Science. 2003;38(15):3159-3168. doi:10.1023/a:1025157114800
  26. Girelli AM, Scuto FR. Eggshell membrane as feedstock in enzyme immobilization. Journal of Biotechnology. 2021;325:241-249. doi:10.1016/j.jbiotec.2020.10.016
  27. Kessi E, Arias JL. Using Natural Waste Material as a Matrix for the Immobilization of Enzymes: Chicken Eggshell Membrane Powder for β-Galactosidase Immobilization. Applied Biochemistry and Biotechnology. 2018;187(1):101-115. doi:10.1007/s12010-018-2805-4
Support